Filing metadata

Accession number
0001140361-21-013549
Form type
Form 3
Filer
Ernexa Therapeutics Inc.
CIK
CIK 748592
Filed
Apr 20, 2021
Reporting period
Apr 16, 2021
Description
Initial ownership

Explore SEC Filings Hub